Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VIROPHARMA INC Cash Flow

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Net Income/Starting Line 67.62 M 95.35 M 66.67 M 113.70 M -19.53 M
    Operating Activities
    Depreciation, Depletion & Amortization 11.99 M 6.92 M 6.17 M 5.54 M 1.18 M
    Depreciation & Depletion 1.18 M 804,000.00 497,000.00 379,000.00 526,000.00
    Amortization of Intangible Assets 10.81 M 6.12 M 5.67 M 5.16 M 650,000.00
    Deferred Income Taxes and Investment Tax credity 0.00 0.00 0.00 0.00 563,000.00
    Deferred Income Taxes 0.00 0.00 0.00 0.00 563,000.00
    Income Tax Credit
    Other Cash Flow 11.99 M 8.22 M 4.52 M 9.21 M 4.81 M
    Funds from Operations 105.43 M 121.97 M 96.74 M 80.70 M -13.54 M
    Extraordinary Items & Discontinued Operations 0.00 0.00
    Funds from/for Other Operating Activities -13.99 M 901,000.00 -1.72 M -9.20 M -6.67 M
    Incline (Decline) in Receivables 8.09 M -10.04 M 4.06 M -7.69 M -8.71 M
    Incline (Decline) in Inventories -3.13 M 57,000.00 6.24 M -9.97 M 0.00
    Incline (Decline) in Accounts Payable 1.57 M -726,000.00 -6.51 M 8.46 M 141,000.00
    Incline (Decline) in Income Taxes Payable -6.08 M -23,000.00 0.00 0.00
    Incline (Decline) in Other Accruals -6.39 M 10.38 M -5.33 M 8.06 M 3.90 M
    Incline (Decline) in Other Assets or Liabilties -8.05 M 1.26 M -174,000.00 -8.05 M -1.99 M
    Net Cash Flow/Operating Activities 91.44 M 122.87 M 95.02 M 71.50 M -20.21 M
    Capital Expenditures (Additions to Fixed Assets)
    Additions to Other Assets 7.00 M 5.95 M 6.65 M 10.49 M 118.03 M
    Net Assets from Acquisitions 380.22 M 0.00 0.00
    Incline (Decline) in Inventories 0.00 789.71 M 1.26 B 292.70 M 218.43 M
    Decrease in Investments 405.19 M 588.35 M 1.06 B 312.20 M 306.66 M
    Disposal of Fixed Assets 0.00 0.00 0.00 0.00 2.11 M
    Other Uses - Investing 0.00 0.00 0.00 0.00 0.00
    Other Sources - Investing 0.00 0.00 0.00 0.00 0.00
    Net Cash Flow - Investing -15.44 M 216.18 M 209.00 M -8.58 M 28.70 M
    Proceeds from Stock Options 0.00 0.00 0.00 279,000.00 0.00
    Other Proceeds from Sale/Issues of Stock 540,000.00 712,000.00 10.86 M 165.06 M 0.00
    Com/Pfd Purchase, Retired, Converted, Redeemed 0.00 0.00 0.00 0.00 0.00
    Financing Activities
    Long Term Borrowings 0.00 241.82 M 0.00 12.50 M 62.50 M
    Incline or Decline in Short Term Borrowings 0.00 0.00 0.00 -8,000.00 0.00
    Reduction in Long Term Debt 12.06 M 0.00 79.60 M 47.63 M 0.00
    Cash Dividends Paid Total 0.00 0.00 0.00 0.00 0.00
    Common Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Preferred Dividends (Cash) 0.00 0.00 0.00 0.00 0.00
    Other Sources - Financing 1.45 M 2.18 M 2.05 M 0.00 0.00
    Other Uses - Financing 1.45 M -21.07 M 2.05 M -806,000.00 -3.83 M
    Net Cash Flow - Financing -10.07 M 221.47 M -66.69 M 129.12 M 58.94 M
    Effect of Exchange rate on Cash -659,000.00 5,000.00
    Changes in Cash and/or Liquid Items